Rocklatan vs Latanoprost after DSLT laser
Treatments studied
Part of Eyes & vision clinical trials.
This study compares two eye drops—Rocklatan and latanoprost—for people with open-angle glaucoma who have already had a laser treatment (DSLT). It tests whether one drop works better than the other at lowering eye pressure after the laser.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older and have open-angle glaucoma in both eyes.
- You are currently using 3 glaucoma eye drops, and one of them is a prostaglandin analog (like Xalatan, Lumigan, or Travatan).
- You have had a laser procedure called DSLT on both eyes, and your eye pressure (after stopping drops) is between 16 and 36 mmHg.
- Your vision is at least 20/60 in both eyes with glasses or contacts.
- You have not had any other glaucoma surgery or laser treatment in the past year.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how the eye drop Rocklatan (a combination of latanoprost and netarsudil) affects blood flow in the back of the eye for people with early open-angle glaucoma. If you already use latanoprost but your eye pressure is still 17 or higher, this trial may explore if adding another medicine improves optic nerve health.
This trial tests a laser treatment called DSLT to see how it affects eye pressure changes over 6 months. It may help people with open-angle glaucoma or high eye pressure who are currently using 0 to 3 types of pressure-lowering eye drops.
This study tests a new laser treatment called DSLT for people who have just been diagnosed with open-angle glaucoma or a similar condition like ocular hypertension. It aims to see if the laser can lower eye pressure by at least 20% after six months without needing any eye drops.
This study tests whether a laser treatment helps keep eye pressure stable in people with early glaucoma or high eye pressure who have not used any eye drops or medications before. It may be a good option if you are looking for a treatment that doesn't require daily eye drops.
This trial tests a type of laser treatment (DSLT) for people of Asian descent who have normal tension glaucoma, where eye pressure stays below 21 mmHg. It aims to see if this laser can help control the disease and possibly reduce the need for eye drops.
This study compares two versions of latanoprost eye drops—one that contains a preservative and one that is preservative-free. It aims to see how each version affects the eye’s “goblet cells,” which help keep the eye surface healthy.
Hear when a new Glaucoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.